Why ChatGPT for Pharmaceuticals introduces significant compliance risks
Pharma teams are exploring generative AI, but public tools risk data integrity and GxP compliance. Lyzr provides a private, validated, and secure alternative for your workflows.
- Achieve GxP compliance
- Deploy in private cloud
- Accelerate document cycles
Lyzr's Compliant AI:
For Pharmaceutical Needs
Lyzr is an enterprise-grade AI platform built for the unique regulatory and data security challenges of the life sciences industry, ensuring control and auditability.
01
Total Data Control
- Deploy in your own VPC or on-premise for full data isolation.
02
Audit Readiness
- Generate comprehensive, immutable audit trails for every AI interaction and action.
03
Validation Support
- Lyzr provides the documentation and controls necessary for system validation in GxP environments.
04
Model Governance
- Enforce strict policies and monitor AI performance to ensure compliance.
AI for Every Pharma
Workflow
Move beyond basic chat with secure, auditable AI agents that automate and accelerate critical pharmaceutical processes from lab to launch.
Regulatory Affairs
Automate document creation for submissions and manage labeling updates.
Pharmacovigilance
Create secure copilots for researchers to query internal trial data and scientific literature.
R&D Knowledge
Create secure copilots for researchers to query internal trial data and scientific literature.
Stop exposing sensitive IP to public AI tools. Lyzr offers a secure, private, and compliant generative AI platform.
Outcomes of GxP-Ready AI
in Your Enterprise
- Accelerate Submission Cycles
Reduce the time spent on manual document drafting and review by up to 60%.
- Lower Compliance Risk
Ensure every AI-assisted action is logged, auditable, and aligned with GxP standards.
- Secure Knowledge Reuse
Unlock insights from proprietary R&D data without ever exposing it to third parties.
- Boost Ops Throughput
Increase capacity in PV and quality assurance without adding headcount.
Enterprise-Grade Platform
for Pharma AI
Our architecture is built from the ground up to meet the stringent security, privacy, and compliance demands of life sciences.
Private LLM Setup
Deploy leading models within your secure environment, ensuring no data ever leaves.
Policy Guardrails
Implement custom rules to control AI behavior and prevent non-compliant outputs.
Immutable Audit Trails
Capture detailed, tamper-proof logs for all prompts, responses, and user actions.
Secure API Integration
Connect Lyzr agents to your existing QMS, RIM, and EDC systems with robust security protocols.
Continuous Monitoring
Track model performance, accuracy, and adherence to policies in real-time.
AI Platform Comparison
for Pharma Use
Lyzr provides a "Bank-in-a-Box" AI framework, ensuring your generative AI banking security matches your most stringent internal standards through total isolation.
Feature
Generic AI Tools
Copywriting AI
Lyzr
Data Isolation
Public Cloud
Shared infrastructure
Private VPC / On-Premise
GxP Readiness
Not designed for GxP
Not applicable
Designed for GxP needs
Audit Logs
Basic or none
Minimal logging
Immutable, detailed logs
Deployment
SaaS only
Multi-tenant SaaS
Flexible deployment model
Access Control
Limited user roles
Basic permissions
Granular, role-based access
Model Governance
No user controls
Vendor controlled
Full user configuration
No, not specific
No, not specific
Not focused
Purpose-built pharma agents
Hallucination Control
No guarantees
Limited fact-checking
Source-grounded responses
Feature
Generic AI Agents
OpenClaw Platform
Lyzr
Deployment Model
Public Cloud SaaS
Self-hosted, complex
Private VPC / On-Premise
Data Privacy
Vendor dependent
Relies on user config
Total data isolation
Execution Engine
Non-deterministic
Often unpredictable
Fully deterministic
Governance
Limited to none
Requires 3rd party tools
Native, built-in
Audit Logs
Basic usage logs
Manual setup
Immutable, automatic
Security Posture
Shared tenant model
Depends on environment
Zero-trust architecture
Not available
Not available
Requires custom code
Automated and native
Model Control
Locked to one API
Community supported
Fully model-agnostic
The Enterprise Choice
for Pharma
Built for GxP
Our platform is designed to operate within validated systems.
Security by Design
We prioritize data privacy and IP protection at every layer of architecture.
Controlled AI
You define the rules, guardrails, and acceptable use policies for AI.
Faster Value
Deploy pre-built agents for common pharma workflows in weeks, not years.
Built Specifically for
Financial Institutions
Join a growing ecosystem of consulting and technology partners
Lyzr's platform has fundamentally changed our approach to regulatory documentation. We've cut our document creation cycle times by over 50% while simultaneously improving our audit trail. Our team is now better prepared for inspections and can focus more on strategy rather than tedious manual work.
Director
Regulatory Operations
Zero
Data Exfiltration Incidents
Deploy Compliant AI for
Pharmaceuticals
- Step - 1
Risk & Scope
Identify high-value use cases and define GxP requirements.
- Step - 2
Secure Deployment
Install Lyzr within your private cloud or on-premise infrastructure.
- Step - 3
Configure Agents
Connect to your data sources and configure AI agents for specific tasks.
- Step - 4
Validate & Scale
Execute validation protocols and roll out solutions across your enterprise.
Frequently asked questions
No, standard ChatGPT is not designed for GxP environments. It lacks the necessary audit trails, validation support, and data controls required for regulated tasks. Lyzr's platform provides these critical features, making it a suitable choice for deployment within a GxP framework and ensuring full compliance.
Lyzr is deployed within your own secure environment, such as a Virtual Private Cloud (VPC) or on-premise. This ensures your sensitive R&D, clinical, and patient data never leaves your control and is never used to train external models.
Yes. Lyzr is designed with validation in mind. We provide comprehensive documentation, support for IQ/OQ/PQ, and built-in controls that streamline the process of validating our platform for use in your regulated pharmaceutical workflows.
While offering more security than the public version, ChatGPT Enterprise is a SaaS tool that may not meet strict data residency or GxP validation needs. Lyzr offers superior control with private deployment, full auditability, and validation support.
Track model performance, accuracy, and adherence to policies in real-time.
Absolutely. Lyzr includes secure connectors for common pharmaceutical systems like Veeva Vault, OpenText, and other QMS or RIM platforms. This allows our AI agents to work directly with your single source of truth for documents and data.
Using public AI for regulated documents poses significant risks, including data leakage, IP loss, lack of auditability, and potential GxP non-compliance. These tools do not meet the stringent requirements for systems used in drug development and manufacturing.
Seat-based pricing becomes costly as you scale. Lyzr offers a consumption-based model that is more predictable and cost-effective for enterprise-wide adoption. You pay for the value and compute you use, not the number of users with access.
Yes. Lyzr's governance layer allows you to set granular, role-based access controls and custom AI usage policies. This means your R&D team can have different guardrails than your Regulatory Affairs team, ensuring appropriate use everywhere.
No, Lyzr is a powerful assistant designed to augment your experts. It handles repetitive, time-consuming tasks like drafting documents and finding information, freeing up your scientists, writers, and reviewers to focus on high-level strategic work.
Secure Your AI Advantage Today
Get a custom architecture review and pilot plan in 48 hours.